These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2109354)

  • 1. Radiotherapy in emergency treatment of malignant exophthalmos.
    Appelqvist P; Salmo M; Rissanen P
    Strahlenther Onkol; 1990 Mar; 166(3):190-3. PubMed ID: 2109354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The current role of radiotherapy in immunogenic exophthalmos].
    Malinverni G; Giordana C; Rosmino C; Mancini A; Sala S
    Radiol Med; 1994 Nov; 88(5):665-9. PubMed ID: 7824786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience of radiation therapy for Graves' ophthalmopathy.
    Takahashi T; Mitsuhashi N; Nagashima H; Sakurai H; Murata O; Ishizeki K; Shimaya S; Hayakawa K; Niibe H
    Radiat Med; 1996; 14(6):343-7. PubMed ID: 9132818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrobulbar irradiation of endocrine ophthalmopathy: a comparison between 10 and 16 Gy total dose].
    Pfluger T; Wendt T; Toroutoglou N; Pickardt C; Wuttge R
    Strahlenther Onkol; 1990 Oct; 166(10):673-7. PubMed ID: 2237752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrobulbar irradiation for Graves' ophthalmopathy -- long-term results].
    Pitz S; Kahaly G; Rösler HP; Krummenauer F; Wagner B; Stübler M; Pfeiffer N
    Klin Monbl Augenheilkd; 2002 Dec; 219(12):876-82. PubMed ID: 12548473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Graves' ophthalmopathy with irradiation].
    Slampa P; Spurný V; Seneklová Z; Krákorová D
    Vnitr Lek; 1998 Aug; 44(8):461-3. PubMed ID: 10358449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of retrobulbar irradiation in case of benign endocrinous ophthalmopathy (author's transl)].
    Fritsch R; Hassenstein E; Dausch D
    Strahlentherapie; 1981 May; 157(5):305-9. PubMed ID: 6787746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated radiotherapy for Graves' orbitopathy.
    Heyd R; Strassmann G; Herkströter M; Martin T; Zamboglou N
    Rontgenpraxis; 2001; 54(3):94-100. PubMed ID: 11799870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiotherapy of endocrine ophthalmopathy using 18-MeV betatron radiation].
    Heinze HG; Pickardt CR; Brand H
    Strahlentherapie; 1974 Sep; 148(3):226-34. PubMed ID: 4141141
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of early and late results of progressive Graves-Basedow ophthalmopathy treatment with different methods].
    Pilarska K; Czekalski S; Syrenicz A; Andrzejewska W; Krzystolik Z; Przerwa D
    Pol Tyg Lek; 1992 Nov 2-9; 47(44-45):1000-3. PubMed ID: 1305709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme.
    Singh D; Banerji AK; Dwarakanath BS; Tripathi RP; Gupta JP; Mathew TL; Ravindranath T; Jain V
    Strahlenther Onkol; 2005 Aug; 181(8):507-14. PubMed ID: 16044218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.
    Wakelkamp IM; Tan H; Saeed P; Schlingemann RO; Verbraak FD; Blank LE; Prummel MF; Wiersinga WM
    Ophthalmology; 2004 Aug; 111(8):1557-62. PubMed ID: 15288988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified method for treating Graves' disease with radioactive 131I.
    Masri MT; Menne M; Rooney BL; Caplan RH
    Wis Med J; 1995 Jan; 94(1):21-5. PubMed ID: 7871797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioiodine therapy of autonomously functioning thyroid nodules and Graves' disease].
    Guhlmann CA; Rendl J; Börner W
    Nuklearmedizin; 1995 Feb; 34(1):20-3. PubMed ID: 7724360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
    Howarth D; Epstein M; Lan L; Tan P; Booker J
    Eur J Nucl Med; 2001 Oct; 28(10):1489-95. PubMed ID: 11685491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small prospective study of chordomas treated with radiotherapy and razoxane.
    Rhomberg W; Böhler FK; Novak H; Dertinger S; Breitfellner G
    Strahlenther Onkol; 2003 Apr; 179(4):249-53. PubMed ID: 12707714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.